UNSPSC 51171843: Maropitant

This classification denotes an antiemetic agent with the molecular formula C32H40N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4XE2T9H4DH, chemically known as (2S,3S)-2-benzhydryl-N-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine but generally known as maropitant, which bears US NIH Compound Identifier 204108. The term MAROPITANT is an International Non-Proprietary Name or INN. Most nations schedule maropitant under HS 29333999 and SITC 51574.

As of Q4 2014, MAROPITANT remains the US FDA Preferred Term for this commodity. Maropitant bears US NLM identifiers UMLS ID C1871004 and NCI Concept Code C81500. SMILES: CC(C)(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3.

UNSPSC 51171843 Maropitant, a Commodity code, does not align with the recent state and local opportunities tagged under it. The three most recent solicitations address offender drug testing services, direct-to-manufacturer pharmacy benefit programs, and generic multi-source pharmaceutical distribution through cooperative purchasing — none of which involve maropitant, an antiemetic veterinary pharmaceutical. The code shows little relevant recent activity for the stated product line.

The mismatch suggests either a tagging error in the state and local procurement system or that maropitant procurement under this code is not currently active in the market. Firms pursuing pharmaceutical-adjacent opportunities should verify the accuracy of UNSPSC coding in RFP and RFQ notices before responding, as the opportunities present here span human pharmaceutical procurement, correctional health services, and cooperative purchasing for state agencies and counties — distinct from single-product animal health procurement.